BIM
SBBP

BlackRock Investment Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

BlackRock Investment Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Hold
1,959
– – ﹤0.01% 3776
2016
Q3 		$10K Hold
1,959
– – ﹤0.01% 3603
2016
Q2 		$8K Buy
1,959
+628
+47% +$2.96K ﹤0.01% 3737
2016
Q1 		$6K Hold
1,331
– – ﹤0.01% 3791
2015
Q4 		$10K Buy
+1,331
New +$9.56K ﹤0.01% 3696

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

BlackRock Investment Management's SBBP Position: Q4 2016 in Review

BlackRock Investment Management held its Strongbridge Biopharma plc. (SBBP) position steady in Q4 2016 at 1,959 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

BlackRock Investment Management first reported a position in SBBP in Q4 2015 and has held it in 5 quarters since. The position peaked at $10K in Q3 2016. 18 funds tracked by Wall St. Rank hold SBBP as of Q4 2016.

  • BlackRock Investment Management held 1,959 shares of Strongbridge Biopharma plc. worth $5K as of Q4 2016.
  • BlackRock Investment Management left its Strongbridge Biopharma plc. share count unchanged in Q4 2016.
  • Strongbridge Biopharma plc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3776 holding.
  • BlackRock Investment Management first reported a position in Strongbridge Biopharma plc. in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Investment Management's Strongbridge Biopharma plc. position peaked at $10K in Q3 2016.
  • 18 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.